Home/Pipeline/Antivirals Platform

Antivirals Platform

Infectious Disease

DiscoveryActive

Key Facts

Indication

Infectious Disease

Phase

Discovery

Status

Active

Company

Qubit Pharmaceuticals

About Qubit Pharmaceuticals

Qubit Pharmaceuticals is a Paris-based, private biotech firm pioneering a quantum-aided drug discovery platform. The company integrates decades of computational chemistry research into its ATLAS platform, which uses quantum mechanics, AI, and hybrid HPC/quantum computing to generate and simulate novel drug candidates with high precision. With a team of over 60 experts and a pipeline of over 20 programs, Qubit is targeting historically undruggable targets in oncology and inflammation while actively seeking partnerships to expand its impact.

View full company profile

Therapeutic Areas

Oncology Inflammation Infectious Disease

Other Infectious Disease Drugs

Drug	Company	Phase	Status
Vaccine Platform	Biolingus	Research	Active
Pipeline Antibiotics	BioQ Pharma	Unknown	Active
Antibiotic Development Program	AF ChemPharm	Pre-clinical	Active
Prophylactic Vaccine Development	ImmuneSpec	Service	Active
Optimized VHH vs. SARS-CoV-2	Ordaos Bio	Pre-clinical	Active
AmorphOX Vaccine	Orexo	Preclinical	Active (with Abera)
Undisclosed Vaccine Program(s)	Brazos Biomedical	Pre-clinical	Active
Undisclosed Asset 1	Uvax Bio	Research	Active
Undisclosed Asset 2	Uvax Bio	Research	Active
Undisclosed Asset 3	Uvax Bio	Research	Active
Vaccine Immune Response (SARS-CoV-2)	CellChorus	Preclinical	Active
POCKIT™ Central COVID-19 Assay	GeneReach Biotechnology	commercial	Active